Columns
 
News > CSBio PET peptide are recognized again

Hits:3054 , posted at 2020/3/11 15:30

27 November 2019Qingqing PanXinxin CaoYaping Luo Jian LiJun FengFang Li Several researchers have published papers

Chemokine receptor-4 targeted PET/CT with 68Ga-Pentixafor in assessment of newly diagnosed multiple myeloma: comparison to 18F-FDG PET/CT

CSBio PET peptide  is honored to be used and to contribute to this achievement.







CSBio Introduction


CSBio is Global peptide company bringing more than 26 years of technical expertise into the peptide industry which cover three main categories of products and services:
1) peptide CDMO & CMO service -GMP and R&D peptide production, with API peptide production approved by USFDA.
2) Peptide Instrumentation - from R&D up to Large Scale Manufacturing-type synthesizer, Cleavage systems, PreHPLC system, Column packing equipment and peptide production technical support.
3) Peptide raw material -- High Quality Standard Grade and High Grade Fmoc-protected Amino Acid, peptide reagents, coupling reagents, resins and special reagents, supported by relevant validated QC data, stability data and DMF technical documents.


CSBio (Shanghai) Ltd.

China (Shanghai) Pilot Free Trade Zone, 85 Faladi Road, Building 2,Room 502 ,Shanghai 201210, China

Email:info@csbiochina.com

Tel:+8621-50781653/50781655

Fax:+8621-50781652/021-50781656

Website: www.csbiochina.com www.csbio.com

 
Home | About Us | Site Map | Career | Contact Us
©CSBio China 2021 有任何问题可以参考总部网站:www.csbio.com      沪公网安备 31011502005552号      沪ICP备13005633号-1